Telesis Bio(TBIO.US)

Last Updated 19:00:00 ET
longbridge loading

Biotalys Reports Full-Year 2025 Financial Results and Business Highlights

Unusual Whales·
US
BTAI
0.00%
US
TBIO
0.00%
US
TLIS
0.00%
Unusual Whales·
US
BTAI
0.00%
US
TBIO
0.00%
US
TLIS
0.00%

Terremoto wins $108m in Series C to drive cancer and rare disease programmes

Pharmaceutical Technology·
US
TBIO
0.00%
US
MBX
-0.16%
US
FBT
-0.72%
Pharmaceutical Technology·
US
TBIO
0.00%
US
MBX
-0.16%
US
FBT
-0.72%

Telesia Extends Timetable for 2025 Accounts and Updates 2026 Financial Calendar

Tip Ranks·
US
LABU
-1.49%
US
IBB
-0.20%
US
XBI
-0.44%
Tip Ranks·
US
LABU
-1.49%
US
IBB
-0.20%
US
XBI
-0.44%

Satellos Bioscience Unveils Positive Interim SAT-3247 Data in Duchenne Muscular Dystrophy at MDA 2026

Tip Ranks·
US
XBI
-0.44%
US
ASMB
-0.50%
US
FBT
-0.72%
Tip Ranks·
US
XBI
-0.44%
US
ASMB
-0.50%
US
FBT
-0.72%

Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular Dystrophy

Tip Ranks·
US
TBIO
0.00%
US
XBI
-0.44%
US
IBB
-0.20%
Tip Ranks·
US
TBIO
0.00%
US
XBI
-0.44%
US
IBB
-0.20%

Stocks in Play: Satellos Bioscience Inc.

Baystreet·
US
IBB
-0.20%
US
SBIO
+0.04%
US
ASMB
-0.50%
Baystreet·
US
IBB
-0.20%
US
SBIO
+0.04%
US
ASMB
-0.50%
© 2026 Longbridge｜Disclaimer